Authors: Krueger, JG Walters, IB Miyazawa, M Gilleaudeau, P Hakimi, J Light, S Sherr, A Gottlieb, AB

Citation: Jg. Krueger et al., Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor)on T cells by administration of humanized anti-Tac antibody to patients with psoriasis, J AM ACAD D, 43(3), 2000, pp. 448-458

Authors: Trepicchio, WL Ozawa, M Walters, IB Kikuchi, T Gilleaudeau, P Bliss, JT Schwertschlag, U Dorner, A Krueger, JG

Citation: Wl. Trepicchio et al., Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions (vol 104, pg 1527, 1999), J CLIN INV, 105(3), 2000, pp. 396-396

Authors: Coven, TR Walters, IB Cardinale, I Krueger, JG

Citation: Tr. Coven et al., PUVA-induced lymphocyte apoptosis: Mechanism of action in psoriasis, PHOTODERM P, 15(1), 1999, pp. 22-27

Authors: Walters, IB Burack, LH Coven, TR Gilleaudeau, P Krueger, JG

Citation: Ib. Walters et al., Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris, J AM ACAD D, 40(6), 1999, pp. 893-900

Authors: Austin, LM Ozawa, M Kikuchi, T Walters, IB Krueger, JG

Citation: Lm. Austin et al., The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients, J INVES DER, 113(5), 1999, pp. 752-759

Authors: Trepicchio, WL Ozawa, M Walters, IB Kikuchi, T Gilleaudeau, P Bliss, JL Schwertschlag, U Dorner, AJ Krueger, JG

Citation: Wl. Trepicchio et al., Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions, J CLIN INV, 104(11), 1999, pp. 1527-1537